Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection versus vaccination
Related Experiment Video
Updated: May 3, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Annette Fox1,2, Annette Alafaci3, Louise Carolan4
1WHO Collaborating Centre for Reference and Research on Influenza Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. annette.fox@unimelb.edu.au.
Insights
Influenza infection in early childhood may prime better antibody responses to A(H3N2) vaccination than prior vaccination. This pilot study found higher antibody titres and seroconversion rates after vaccination in children with a history of influenza A(H3N2) infection.
Area of Science:
- Immunology
- Pediatrics
- Vaccinology
Background:
- Annual influenza vaccination is recommended for children.
- The impact of early life influenza exposure (infection vs. vaccination) on subsequent immunity is not well understood.
- This study investigates how prior influenza A(H3N2) infection versus vaccination influences immune responses to subsequent influenza vaccination in young children.
Purpose of the Study:
- To examine the effect of early life influenza A(H3N2) infection versus vaccination on subsequent antibody responses to influenza vaccination.
- To compare antibody titres and seroconversion rates after vaccination in children with different prior influenza exposure histories.
Main Methods:
- Pilot study involving 19 children aged 6-60 months in Australia (2019-2021).
- Plasma collected pre- and post-vaccination over up to three years.
- Antibody titres measured using hemagglutination inhibition (HI), neuraminidase inhibition (NI) assays, and ELISA.
- Children classified based on prior vaccination or influenza A(H3N2) infection history.
Main Results:
- Post-vaccination antibody titres and titre-rises against A(H3N2) were significantly higher in children with prior infection compared to prior vaccination.
- Seroconversion rates for A(H3N2) were 8/8 in the prior infection group versus 3/7 in the prior vaccination group.
- Antibody responses to A(H1N1) did not differ significantly between groups.
Conclusions:
- Prior influenza A(H3N2) infection may be superior to vaccination in priming subsequent vaccine antibody responses against A(H3N2).
- Findings suggest a potential difference in immunological imprinting based on the type of early influenza exposure.
Background:
Annual influenza vaccination is recommended for young children with limited understanding of how this may imprint influenza immunity. We conducted a pilot study to examine whether early life exposure to influenza through vaccination versus infection affects subsequent vaccination responses.
Methods:
Nineteen children aged 6-60 months were enrolled at two Australian hospitals during 2019-2021. Plasma was collected before and after vaccination for up to three successive years to measure antibody titres by hemagglutinination (HA) and neuraminidase (NA) inhibiting (HI, NI) assays and ELISA. Medical records and seropositivity (HI titre ≥40) at enrolment were used to classify seven children as having prior vaccination(s) and eight as having prior influenza A(H3N2) infection. Others had mixed, no, or unclear prior exposures. Post-vaccination antibody titres and seroconversion (HI fold-rise ≥4) were compared across the two main prior exposure groups.
Results:
Here we show that post-vaccination HI and NI antibody titres and titre-rises against A(H3N2) are far higher among children classified as having had prior A(H3N2) infection compared to prior vaccination; 8/8 versus 3/7 seroconverted, respectively. A(H3N2) HA-stem binding antibody titres are modest but rise more after vaccination among children classified as having had prior A(H3N2) infection. A(H1N1)-reactive antibody responses are not significantly different between groups.
Conclusions:
These results suggest that for priming subsequent vaccine antibody responses against A(H3N2), infection may be superior to vaccination.
More Related Videos
Related Concept Videos
Vaccinations
Vaccines
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Influenza
Cross-reactivity
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

